{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T01:15:57Z","timestamp":1775092557051,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T00:00:00Z","timestamp":1485216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T00:00:00Z","timestamp":1485216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nasopharyngeal carcinoma (NPC) is a serious threat to public health, and the biomarker discovery is of urgent needs. The data-independent mode (DIA) based sequential window acquisition of all theoretical fragment-ion spectra (SWATH) mass spectrometry (MS) has been proved to be precise in protein quantitation and efficient for cancer biomarker researches. In this study, we performed the first SWATH-MS analysis comparing the NPC and normal tissues. Spike-in stable isotope labeling by amino acids in cell culture (super-SILAC) MS was used as a shotgun reference. We identified and quantified 1414 proteins across all SWATH-MS analyses. We found that SWATH-MS had a unique feature to preferentially detect proteins with smaller molecular weights than either super-SILAC MS or human proteome background. With SWATH-MS, 29 significant differentially express proteins (DEPs) were identified. Among them, carbonic anhydrase 2 (CA2) was selected for further validation per novelty, MS quality and other supporting rationale. With the tissue microarray analysis, we found that CA2 had an AUC of 0.94 in differentiating NPC from normal tissue samples. In conclusion, SWATH-MS has unique features in proteome analysis, and it leads to the identification of CA2 as a potentially new diagnostic biomarker for NPC.<\/jats:p>","DOI":"10.1038\/srep41191","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T10:42:42Z","timestamp":1485254562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["SWATH-based proteomics identified carbonic anhydrase 2 as a potential diagnosis biomarker for nasopharyngeal carcinoma"],"prefix":"10.1038","volume":"7","author":[{"given":"Yanzhang","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tin Seak","family":"Mok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuxian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhi","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,24]]},"reference":[{"key":"BFsrep41191_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.21037\/cco.2016.03.12","volume":"5","author":"C Xu","year":"2016","unstructured":"Xu, C., Chen, Y. P. & Ma, J. Clinical trials in nasopharyngeal carcinoma-past, present and future. Chin Clin Oncol 5, 20, doi: 10.21037\/cco.2016.03.12 (2016).","journal-title":"Chin Clin Oncol"},{"key":"BFsrep41191_CR2","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s40880-015-0018-6","volume":"34","author":"LF Zhang","year":"2015","unstructured":"Zhang, L. F. et al. Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age-period-cohort analysis. Chin J Cancer 34, 350\u2013357, doi: 10.1186\/s40880-015-0018-6 (2015).","journal-title":"Chin J Cancer"},{"key":"BFsrep41191_CR3","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.ijrobp.2004.07.702","volume":"61","author":"AW Lee","year":"2005","unstructured":"Lee, A. W. et al. Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61, 1107\u20131116, doi: 10.1016\/j.ijrobp.2004.07.702 (2005).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"BFsrep41191_CR4","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/S1470-2045(16)30410-7","volume":"17","author":"Y Sun","year":"2016","unstructured":"Sun, Y. et al. Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial. Lancet Oncol 17, 1509\u20131520, doi: 10.1016\/S1470-2045(16)30410-7 (2016).","journal-title":"Lancet Oncol"},{"key":"BFsrep41191_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/path.4781","volume":"240","author":"SB Ye","year":"2016","unstructured":"Ye, S. B. et al. Exosomal miR-24-3p impedes T-cell function by targeting FGF11 and serves as a potential prognostic biomarker for nasopharyngeal carcinoma. J Pathol 240, 329\u2013340, doi: 10.1002\/path.4781 (2016).","journal-title":"J Pathol"},{"key":"BFsrep41191_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.21037\/cco.2016.03.09","volume":"5","author":"T Spence","year":"2016","unstructured":"Spence, T., Bruce, J., Yip, K. W. & Liu, F. F. MicroRNAs in nasopharyngeal carcinoma. Chin Clin Oncol 5, 17, doi: 10.21037\/cco.2016.03.09 (2016).","journal-title":"Chin Clin Oncol"},{"key":"BFsrep41191_CR7","doi-asserted-by":"crossref","unstructured":"Zou, Z. W. et al. LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells. Oncotarget, doi: 10.18632\/oncotarget.11437 (2016).","DOI":"10.18632\/oncotarget.11437"},{"key":"BFsrep41191_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ijc.11130","volume":"105","author":"KH Chan","year":"2003","unstructured":"Chan, K. H. et al. EBV specific antibody-based and DNA-based assays in serologic diagnosis of nasopharyngeal carcinoma. Int J Cancer 105, 706\u2013709, doi: 10.1002\/ijc.11130 (2003).","journal-title":"Int J Cancer"},{"key":"BFsrep41191_CR9","first-page":"1155","volume":"62","author":"Y Chen","year":"2016","unstructured":"Chen, Y. et al. Diagnostic Value of Serum Epstein-Barr Virus Capsid Antigen-IgA for Nasopharyngeal Carcinoma: a Meta-Analysis Based on 21 Studies. Clin Lab 62, 1155\u20131166 (2016).","journal-title":"Clin Lab"},{"key":"BFsrep41191_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21037\/cco.2016.03.07","volume":"5","author":"SY Fung","year":"2016","unstructured":"Fung, S. Y., Lam, J. W. & Chan, K. C. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma. Chin Clin Oncol 5, 18, doi: 10.21037\/cco.2016.03.07 (2016).","journal-title":"Chin Clin Oncol"},{"key":"BFsrep41191_CR11","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1200\/JCO.2006.07.7982","volume":"24","author":"SF Leung","year":"2006","unstructured":"Leung, S. F. et al. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma. J Clin Oncol 24, 5414\u20135418, doi: 10.1200\/JCO.2006.07.7982 (2006).","journal-title":"J Clin Oncol"},{"key":"BFsrep41191_CR12","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1158\/0008-5472.CAN-06-0094","volume":"66","author":"LB Song","year":"2006","unstructured":"Song, L. B. et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 66, 6225\u20136232, doi: 10.1158\/0008-5472.CAN-06-0094 (2006).","journal-title":"Cancer Res"},{"key":"BFsrep41191_CR13","doi-asserted-by":"crossref","unstructured":"Wu, T. et al. HMGB1 overexpression as a prognostic factor for survival in cancer: a meta-analysis and systematic review. Oncotarget, doi: 10.18632\/oncotarget.10413 (2016).","DOI":"10.18632\/oncotarget.10413"},{"key":"BFsrep41191_CR14","doi-asserted-by":"publisher","first-page":"e0152820","DOI":"10.1371\/journal.pone.0152820","volume":"11","author":"YF Lian","year":"2016","unstructured":"Lian, Y. F. et al. Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma. PLoS One 11, e0152820, doi: 10.1371\/journal.pone.0152820 (2016).","journal-title":"PLoS One"},{"key":"BFsrep41191_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1586\/14789450.2014.897613","volume":"11","author":"L Xiao","year":"2014","unstructured":"Xiao, L., Xiao, T., Wang, Z. M., Cho, W. C. & Xiao, Z. Q. Biomarker discovery of nasopharyngeal carcinoma by proteomics. Expert Rev Proteomics 11, 215\u2013225, doi: 10.1586\/14789450.2014.897613 (2014).","journal-title":"Expert Rev Proteomics"},{"key":"BFsrep41191_CR16","doi-asserted-by":"publisher","first-page":"34022","DOI":"10.18632\/oncotarget.9067","volume":"7","author":"Z Chen","year":"2016","unstructured":"Chen, Z. et al. Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS\/MS. Oncotarget 7, 34022\u201334037, doi: 10.18632\/oncotarget.9067 (2016).","journal-title":"Oncotarget"},{"key":"BFsrep41191_CR17","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1021\/acs.jproteome.5b00499","volume":"14","author":"GS Omenn","year":"2015","unstructured":"Omenn, G. S. et al. Metrics for the Human Proteome Project 2015: Progress on the Human Proteome and Guidelines for High-Confidence Protein Identification. J Proteome Res 14, 3452\u20133460, doi: 10.1021\/acs.jproteome.5b00499 (2015).","journal-title":"J Proteome Res"},{"key":"BFsrep41191_CR18","doi-asserted-by":"publisher","first-page":"O111 016717","DOI":"10.1074\/mcp.O111.016717","volume":"11","author":"LC Gillet","year":"2012","unstructured":"Gillet, L. C. et al. Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics 11, O111 016717, doi: 10.1074\/mcp.O111.016717 (2012).","journal-title":"Mol Cell Proteomics"},{"key":"BFsrep41191_CR19","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/pmic.201600203","volume":"16","author":"R Aebersold","year":"2016","unstructured":"Aebersold, R., Bensimon, A., Collins, B. C., Ludwig, C. & Sabido, E. Applications and Developments in Targeted Proteomics: From SRM to DIA\/SWATH. Proteomics 16, 2065\u20132067, doi: 10.1002\/pmic.201600203 (2016).","journal-title":"Proteomics"},{"key":"BFsrep41191_CR20","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/msb.2008.61","volume":"4","author":"V Lange","year":"2008","unstructured":"Lange, V., Picotti, P., Domon, B. & Aebersold, R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4, 222, doi: 10.1038\/msb.2008.61 (2008).","journal-title":"Mol Syst Biol"},{"key":"BFsrep41191_CR21","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nmeth.2015","volume":"9","author":"P Picotti","year":"2012","unstructured":"Picotti, P. & Aebersold, R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods 9, 555\u2013566, doi: 10.1038\/nmeth.2015 (2012).","journal-title":"Nat Methods"},{"key":"BFsrep41191_CR22","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1074\/mcp.M114.038273","volume":"13","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol Cell Proteomics 13, 1753\u20131768, doi: 10.1074\/mcp.M114.038273 (2014).","journal-title":"Mol Cell Proteomics"},{"key":"BFsrep41191_CR23","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1002\/pmic.201500236","volume":"15","author":"Q Lin","year":"2015","unstructured":"Lin, Q. et al. Analysis of colorectal cancer glyco-secretome identifies laminin beta-1 (LAMB1) as a potential serological biomarker for colorectal cancer. Proteomics 15, 3905\u20133920, doi: 10.1002\/pmic.201500236 (2015).","journal-title":"Proteomics"},{"key":"BFsrep41191_CR24","doi-asserted-by":"crossref","unstructured":"Wu, W., Yong, W. W. & Chung, M. C. A simple biomarker scoring matrix for early gastric cancer detection. Proteomics, doi: 10.1002\/pmic.201600194 (2016).","DOI":"10.1002\/pmic.201600194"},{"key":"BFsrep41191_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jprot.2016.02.010","volume":"138","author":"I Ortea","year":"2016","unstructured":"Ortea, I., Rodriguez-Ariza, A., Chicano-Galvez, E., Arenas Vacas, M. S. & Jurado Gamez, B. Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction. J Proteomics 138, 106\u2013114, doi: 10.1016\/j.jprot.2016.02.010 (2016).","journal-title":"J Proteomics"},{"key":"BFsrep41191_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1471-2105-5-203","volume":"5","author":"N Pavelka","year":"2004","unstructured":"Pavelka, N. et al. A power law global error model for the identification of differentially expressed genes in microarray data. BMC Bioinformatics 5, 203, doi: 10.1186\/1471-2105-5-203 (2004).","journal-title":"BMC Bioinformatics"},{"key":"BFsrep41191_CR27","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1074\/mcp.M700240-MCP200","volume":"7","author":"N Pavelka","year":"2008","unstructured":"Pavelka, N. et al. Statistical similarities between transcriptomics and quantitative shotgun proteomics data. Mol Cell Proteomics 7, 631\u2013644, doi: 10.1074\/mcp.M700240-MCP200 (2008).","journal-title":"Mol Cell Proteomics"},{"key":"BFsrep41191_CR28","doi-asserted-by":"crossref","unstructured":"Chen, Z. et al. Cytoskeleton-centric protein transportation by exosomes transforms tumor-favorable macrophages. Oncotarget, doi: 10.18632\/oncotarget.11794 (2016).","DOI":"10.18632\/oncotarget.11794"},{"key":"BFsrep41191_CR29","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1002\/pmic.200701034","volume":"8","author":"CC Wu","year":"2008","unstructured":"Wu, C. C. et al. Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation. Proteomics 8, 3605\u20133620, doi: 10.1002\/pmic.200701034 (2008).","journal-title":"Proteomics"},{"key":"BFsrep41191_CR30","doi-asserted-by":"publisher","first-page":"4743","DOI":"10.1093\/nar\/gkt178","volume":"41","author":"T Wang","year":"2013","unstructured":"Wang, T. et al. Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific. Nucleic Acids Res 41, 4743\u20134754, doi: 10.1093\/nar\/gkt178 (2013).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep41191_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1039\/c4mb00462k","volume":"11","author":"J Guo","year":"2015","unstructured":"Guo, J., Lian, X., Zhong, J., Wang, T. & Zhang, G. Length-dependent translation initiation benefits the functional proteome of human cells. Mol Biosyst 11, 370\u2013378, doi: 10.1039\/c4mb00462k (2015).","journal-title":"Mol Biosyst"},{"key":"BFsrep41191_CR32","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/pmic.201400270","volume":"15","author":"Q Huang","year":"2015","unstructured":"Huang, Q. et al. SWATH enables precise label-free quantification on proteome scale. Proteomics 15, 1215\u20131223, doi: 10.1002\/pmic.201400270 (2015).","journal-title":"Proteomics"},{"key":"BFsrep41191_CR33","first-page":"7075","volume":"60","author":"CC Wykoff","year":"2000","unstructured":"Wykoff, C. C. et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60, 7075\u20137083 (2000).","journal-title":"Cancer Res"},{"key":"BFsrep41191_CR34","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran, C. T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7, 168\u2013181, doi: 10.1038\/nrd2467 (2008).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep41191_CR35","doi-asserted-by":"publisher","first-page":"8168","DOI":"10.3748\/wjg.v22.i36.8168","volume":"22","author":"P Viikila","year":"2016","unstructured":"Viikila, P. et al. Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas. World J Gastroenterol 22, 8168\u20138177, doi: 10.3748\/wjg.v22.i36.8168 (2016).","journal-title":"World J Gastroenterol"},{"key":"BFsrep41191_CR36","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/prca.201500016","volume":"10","author":"S Kurono","year":"2016","unstructured":"Kurono, S. et al. Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography\/nanoelectrospray ionization-mass spectrometry. Proteomics Clin Appl 10, 605\u2013613, doi: 10.1002\/prca.201500016 (2016).","journal-title":"Proteomics Clin Appl"},{"key":"BFsrep41191_CR37","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1084\/jem.20151739","volume":"213","author":"EK Henry","year":"2016","unstructured":"Henry, E. K. et al. Carbonic anhydrase enzymes regulate mast cell-mediated inflammation. J Exp Med 213, 1663\u20131673, doi: 10.1084\/jem.20151739 (2016).","journal-title":"J Exp Med"},{"key":"BFsrep41191_CR38","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/0016-5085(95)90143-4","volume":"108","author":"SC Gordon","year":"1995","unstructured":"Gordon, S. C. et al. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology 108, 1802\u20131809 (1995).","journal-title":"Gastroenterology"},{"key":"BFsrep41191_CR39","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.clinbiochem.2011.09.014","volume":"44","author":"A Alver","year":"2011","unstructured":"Alver, A. et al. Carbonic anhydrase II autoantibody and oxidative stress in rheumatoid arthritis. Clin Biochem 44, 1385\u20131389, doi: 10.1016\/j.clinbiochem.2011.09.014 (2011).","journal-title":"Clin Biochem"},{"key":"BFsrep41191_CR40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/cdli.2.2.209-213.1995","volume":"2","author":"MW Hornef","year":"1995","unstructured":"Hornef, M. W., Wagner, H. J., Kruse, A. & Kirchner, H. Cytokine production in a whole-blood assay after Epstein-Barr virus infection in vivo . Clin Diagn Lab Immunol 2, 209\u2013213 (1995).","journal-title":"Clin Diagn Lab Immunol"},{"key":"BFsrep41191_CR41","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.18632\/oncotarget.2608","volume":"5","author":"W Fang","year":"2014","unstructured":"Fang, W. et al. EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy. Oncotarget 5, 12189\u201312202, doi: 10.18632\/oncotarget.2608 (2014).","journal-title":"Oncotarget"},{"key":"BFsrep41191_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2174\/138920209788488481","volume":"10","author":"M Wu","year":"2009","unstructured":"Wu, M., Li, X., Li, X. & Li, G. Signaling Transduction Network Mediated by Tumor Suppressor\/Susceptibility Genes in NPC. Curr Genomics 10, 216\u2013222, doi: 10.2174\/138920209788488481 (2009).","journal-title":"Curr Genomics"},{"key":"BFsrep41191_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/carcin\/bgh312","volume":"26","author":"J Ma","year":"2005","unstructured":"Ma, J. et al. Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis 26, 281\u2013291, doi: 10.1093\/carcin\/bgh312 (2005).","journal-title":"Carcinogenesis"},{"key":"BFsrep41191_CR44","first-page":"107","volume":"117","author":"Z Li","year":"2004","unstructured":"Li, Z. et al. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines. Chin Med J (Engl) 117, 107\u2013114 (2004).","journal-title":"Chin Med J (Engl)"},{"key":"BFsrep41191_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.canlet.2013.01.052","volume":"335","author":"MC Lo","year":"2013","unstructured":"Lo, M. C. et al. Role of MIF\/CXCL8\/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres. Cancer Lett 335, 81\u201392, doi: 10.1016\/j.canlet.2013.01.052 (2013).","journal-title":"Cancer Lett"},{"key":"BFsrep41191_CR46","doi-asserted-by":"publisher","first-page":"3693","DOI":"10.1021\/pr501103r","volume":"14","author":"Y Chen","year":"2015","unstructured":"Chen, Y. et al. Identification of Missing Proteins Defined by Chromosome-Centric Proteome Project in the Cytoplasmic Detergent-Insoluble Proteins. J Proteome Res 14, 3693\u20133709, doi: 10.1021\/pr501103r (2015).","journal-title":"J Proteome Res"},{"key":"BFsrep41191_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/nprot.2010.192","volume":"6","author":"T Geiger","year":"2011","unstructured":"Geiger, T. et al. Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics. Nat Protoc 6, 147\u2013157, doi: 10.1038\/nprot.2010.192 (2011).","journal-title":"Nat Protoc"},{"key":"BFsrep41191_CR48","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1021\/acs.jproteome.5b00480","volume":"14","author":"L Yang","year":"2015","unstructured":"Yang, L. et al. Finding Missing Proteins from the Epigenetically Manipulated Human Cell with Stringent Quality Criteria. J Proteome Res 14, 3645\u20133657, doi: 10.1021\/acs.jproteome.5b00480 (2015).","journal-title":"J Proteome Res"},{"key":"BFsrep41191_CR49","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat Methods 6, 359\u2013362, doi: 10.1038\/nmeth.1322 (2009).","journal-title":"Nat Methods"},{"key":"BFsrep41191_CR50","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1021\/acs.jproteome.6b00391","volume":"15","author":"J Guo","year":"2016","unstructured":"Guo, J. et al. Phosphoproteome Characterization of Human Colorectal Cancer SW620 Cell-Derived Exosomes and New Phosphosite Discovery for C-HPP. J Proteome Res 15, 4060\u20134072, doi: 10.1021\/acs.jproteome.6b00391 (2016).","journal-title":"J Proteome Res"},{"key":"BFsrep41191_CR51","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.bbrc.2014.06.008","volume":"450","author":"S Shen","year":"2014","unstructured":"Shen, S. et al. Functional proteomics revealed IL-1beta amplifies TNF downstream protein signals in human synoviocytes in a TNF-independent manner. Biochem Biophys Res Commun 450, 538\u2013544, doi: 10.1016\/j.bbrc.2014.06.008 (2014).","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep41191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep41191","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep41191.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:49:54Z","timestamp":1671842994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep41191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,13]]}},"alternative-id":["BFsrep41191"],"URL":"https:\/\/doi.org\/10.1038\/srep41191","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,24]]},"assertion":[{"value":"14 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41191"}}